Stop debating “is it GxP” for weeks
Modern life sciences teams adopt tools fast. If classification is slow, controls become inconsistent. A 60-second classification method keeps everyone aligned and creates a defensible audit trail.
The 4 questions
1) Does it create, modify, or store regulated records?
2) Does it support a quality decision? Think deviations, CAPA, release readiness, stability, complaints, training, supplier quality.
3) Does it transform critical data? Exports, ETL, dashboards, calculations, mappings.
4) Is it the system of record? If yes, higher control expectation.
What to do with the answer
If mostly yes, treat it as GxP and apply risk-based CSV. If mostly no, document rationale and apply standard IT controls. If mixed, define boundaries: which workflows are in scope and which are not.
Fast classification does not lower compliance. It prevents uncontrolled adoption and creates clarity that auditors respect.
In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.